What is the main business of Carcinovit?

The main business activity of Carcinovit focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 8, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Mikołaja Kopernika 15, 62-020 Swarzędz.

What is the share capital?

The share capital of the company is PLN 20,000 (approx. $5,402).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.

What was the revenue?

In 2020, the company generated total revenue of $73.

No, the company recorded a net loss of $16 in 2020. For comparison, in 2019 the loss was $695, meaning the company reduced its loss by 97.6%.

Carcinovitsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-07-08

Share capital

20,000.00 PLN

Registered address

ul. Mikołaja Kopernika 15, 62-020 Swarzędz, Poland

Electronic delivery address

AE:PL-80723-98828-RGFBA-34

Financials

Revenue history

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 654 days for 2018).

2021not filed
202030/11/2022
201922/06/2021
201829/04/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue

This companyUSD 73.44MedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -16.34MedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 89.24MedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 1.01kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Paweł Bystry – President of the Management Board

Manner of representation

Each member of the management board independently is authorized to make declarations of will and sign on behalf of the company, provided that for making declarations concerning the company’s property rights and obligations exceeding PLN 50,000.00 (fifty thousand zloty), two members of the management board acting jointly are authorized.

Ownership

Owner	Shares	Share value	Stake
Paweł Bystryage 40	49	$2,647.22	49%
MED Real Estate sp. z o.o.	25	$1,350.62	25%
Andrzej Jan Wasylewskiage 79	26	$1,404.65	26%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Sonomedical Pluciński, Wojciechowski, Wituskisp. j.	$1,264,523.63	sonomedical.pl
Medaidsp. z o.o.	$1,034,514.88	medaid.pl
Meditechsp. z o.o.	$934,565.46	meditech.pl
PNN Pharmaceuticals sp. z o.o.sp. k.	$267,897.16	pnn.com.pl
Medicallenssp. z o.o.	$179,960.83	medicallens.com
Integris Medical Polskasp. z o.o.	$159,033.76	integrismedical.pl
Aptekssp. z o.o.	$13,537.42	apteks.com
HA Technologiessp. z o.o.	$206.67	amalian.pl
Medventissp. z o.o.	–	medventis.pl
LAB Path Expertssp. z o.o.	–	labpathexperts.com

Change history

Date	Event
2020-01-08	Address change (Ul. Garncarska 8/3, 31-115, Kraków → Ul. Mikołaja Kopernika 15, 62-020, Swarzędz)
2019-07-01	Business resumed
2017-07-01	Business suspended
2017-03-02	Address change (Ul. Kruszynowa 3, 44-100, Gliwice → Ul. Garncarska 8/3, 31-115, Kraków)
2015-07-08	Entered in the register

FAQ

Last updated: 2026-04-13